APOE and Alzheimer disease: Approximately 9–23% of humans express at least one APOE ε4 allele (Jia et al., 2020), a prevalence that varies by race and ethnicity, which increases AD risk with even higher risk in APOE ε4 homozygotes (Serrano-Pozo et al., 2011).